M. Ayanoglu Et Al. , "Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation," BRAIN & DEVELOPMENT , vol.42, no.5, pp.418-420, 2020
Ayanoglu, M. Et Al. 2020. Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. BRAIN & DEVELOPMENT , vol.42, no.5 , 418-420.
Ayanoglu, M., Korgali, E., Sezer, T., Aydin, H. I., & Sonmez, F. M., (2020). Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. BRAIN & DEVELOPMENT , vol.42, no.5, 418-420.
Ayanoglu, Muge Et Al. "Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation," BRAIN & DEVELOPMENT , vol.42, no.5, 418-420, 2020
Ayanoglu, Muge Et Al. "Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation." BRAIN & DEVELOPMENT , vol.42, no.5, pp.418-420, 2020
Ayanoglu, M. Et Al. (2020) . "Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation." BRAIN & DEVELOPMENT , vol.42, no.5, pp.418-420.
@article{article, author={Muge Ayanoglu Et Al. }, title={Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation}, journal={BRAIN & DEVELOPMENT}, year=2020, pages={418-420} }